文献速递神经肿瘤

异柠檬酸脱氢酶分层原发性和复发性人胶质瘤的免疫景观

Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas.
PubMed 文献 · Neuro Oncol · 2024-01-01

研究发现22种免疫细胞类型参与胶质瘤免疫,胶质瘤复发时脑驻留小胶质细胞减少而CD8+ T淋巴细胞增加,且与IDH状态无关;IDH野生型相关模式表现为抗原提呈细胞样小胶质细胞丰富和细胞毒性CD8+ T细胞增多。研究还发现表达颗粒溶素的炎症性小胶质细胞亚群,并提供定义巨噬细胞极化的基因组框架和胶质瘤特异性肿瘤免疫微环境参考特征(GlioTIME-36)。

要点

  • 胶质瘤复发时脑驻留小胶质细胞减少而CD8+ T淋巴细胞增加,与IDH状态无关。
  • IDH野生型相关模式表现为抗原提呈细胞样小胶质细胞丰富和细胞毒性CD8+ T细胞增多。
  • 发现表达颗粒溶素的炎症性小胶质细胞亚群,并提供GlioTIME-36参考特征用于转录组数据解卷积。

核心结论

  • 本研究提供了人全胶质瘤免疫构成的先进视角,可作为转化和临床应用的指南。

主要发现

  • 研究鉴定出22种不同的免疫细胞类型参与胶质瘤免疫。
  • 胶质瘤复发时脑驻留小胶质细胞减少,同时CD8+ T淋巴细胞增加,与IDH状态无关。
  • IDH野生型相关模式表现为抗原提呈细胞样小胶质细胞丰富和细胞毒性CD8+ T细胞增多。
  • 研究还发现表达颗粒溶素的炎症性小胶质细胞亚群,颗粒溶素是一种细胞毒性肽,通常仅在淋巴细胞中表达。
  • 研究提供了定义巨噬细胞极化超越M1/M2范式的基因组框架,以及胶质瘤特异性肿瘤免疫微环境参考特征(GlioTIME-36)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human gliomas are classified using isocitrate dehydrogenase (IDH) status as a prognosticator; however, the influence of genetic differences and treatment effects on ensuing immunity remains unclear. METHODS: In this study, we used sequential single-cell transcriptomics on 144 678 and spectral cytometry on over 2 million immune cells encompassing 48 human gliomas to decipher their immune landscape. RESULTS: We identified 22 distinct immune cell types that contribute to glioma immunity. Specifically, brain-resident microglia (MG) were reduced with a concomitant increase in CD8+ T lymphocytes during glioma recurrence independent of IDH status. In contrast, IDH-wild type-associated patterns, such as an abundance of antigen-presenting cell-like MG and cytotoxic CD8+ T cells, were observed. Beyond elucidating the differences in IDH, relapse, and treatment-associated immunity, we discovered novel inflammatory MG subpopulations expressing granulysin, a cytotoxic peptide that is otherwise expressed in lymphocytes only. Furthermore, we provide a robust genomic framework for defining macrophage polarization beyond M1/M2 paradigm and reference signatures of glioma-specific tumor immune microenvironment (termed GlioTIME-36) for deconvoluting transcriptomic datasets. CONCLUSIONS: This study provides advanced optics of the human pan-glioma immune contexture as a valuable guide for translational and clinical applications.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Gupta P, Dang M, Oberai S, et al. Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas. Neuro Oncol. 2024. PMID: 39126294. doi:10.1093/neuonc/noae139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。